Search results
Found 21853 matches for
The RECOVERY trial was established in March as a randomised clinical trial to test a range of potential treatments for COVID-19, including lopinavir-ritonavir, an antiviral treatment commonly used to treat HIV. There was no significant difference in the primary endpoint of 28-day mortality, and the results were consistent in different subgroups of patients. There was also no evidence of beneficial effects on the risk of progression to mechanical ventilation or length of hospital stay. The trial Steering Committee concluded that there is no beneficial effect of lopinavir-ritonavir in patients hospitalised with COVID-19 and closed that treatment arm.
IHTM Reunion Programme
The schedule for the two day reunion event held in April 2025.
HIE Podcast Caitlin Dolkart and Flare
A transcript of the HIE podcast with Caitlin Dolkart and Bruno Holthof
HIE Podcast Charles Antoine Janssen
The transcript from a podcast with Charles Antoine Janssen and Bruno Holthof in September 2024
Rita Hendrikusdottir and Regmetrics
A transcript from the podcast from the HIE series for IHTM
MSc HSIE Information leaflet
Information about the MSc in Health Service Improvement and Evaluation
Beware - Understanding Evidence in Global Health
Transcript for IHTM podcast Beware - Understanding Evidence in Global Health
Podcast 4 Understanding Evidence in Global Health.pdf (96 KB)
Breaking Down Barriers in Global Health
Transcript for IHTM podcast Breaking Down Barriers in Global Health
Podcast 3 Breaking Down Barriers in Global Health.pdf (101 KB)
Listen & act: Accessing healthy, affordable food for Oxfordshire’s children
Proceedings of a Roundtable on Addressing Child Food Poverty in Oxfordshire. Authors: Shobhana Nagraj, Fiona Steel, Claire Gray, Amy Paterson, Kelsi Farrington.